The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.
Potential blockbusters and root-cause treatments from Eli Lilly, Merck, Takeda and others could get a regulatory nod this ...
The US saw several new and expanded FDA indications this year. The top 5 most-read FDA approvals on AJMC.com included 4 novel ...
Medical Device Network on MSN
Stereotaxis secures FDA approval for ablation catheter
The MAGiC catheter is designed to perform minimally invasive cardiac ablation procedures that treat various forms of ...
Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...
Stocktwits on MSN
Novo Nordisk offers oral Wegovy pill at $149 a month following FDA’s approval in December: Retail tells shorts 'it's time to give up'
However, the price of the 4 mg dose will rise to $199 a month from April 15, 2026, the company said. ・There are no ...
The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...
Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...
46 new molecular entities cleared the agency’s hurdles last year, 4 fewer than in 2024 ...
Vanda Pharmaceuticals has received FDA approval for Nereus (tradipitant), an oral NK-1 receptor antagonist developed to prevent motion-induced vomiting. The approval makes Nereus the first new ...
FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...
The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback